103 related articles for article (PubMed ID: 16966961)
21. Comparison of in vivo and in vitro measures of beryllium sensitization.
Bobka CA; Stewart LA; Engelken GJ; Golitz LE; Newman LS
J Occup Environ Med; 1997 Jun; 39(6):540-7. PubMed ID: 9211212
[TBL] [Abstract][Full Text] [Related]
22. Sarcoidosis and chronic beryllium disease: similarities and differences.
Mayer AS; Hamzeh N; Maier LA
Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of beryllium sensitization among aluminium smelter workers.
Taiwo OA; Slade MD; Cantley LF; Kirsche SR; Wesdock JC; Cullen MR
Occup Med (Lond); 2010 Oct; 60(7):569-71. PubMed ID: 20610489
[TBL] [Abstract][Full Text] [Related]
24. Statistical methods for the blood beryllium lymphocyte proliferation test.
Frome EL; Smith MH; Littlefield LG; Neubert RL; Colyer SP
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):957-68. PubMed ID: 8933042
[TBL] [Abstract][Full Text] [Related]
25. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
[TBL] [Abstract][Full Text] [Related]
27. Interstitial pneumonia in a glassblower: think to chronic beryllium disease!
Jamoussi A; Merhabene T; Mlika M; Neji H; El Mezni F; Khelil JB; Besbes M
Pan Afr Med J; 2018; 31():95. PubMed ID: 31011396
[TBL] [Abstract][Full Text] [Related]
28. Beryllium BioBank: 2. Lymphocyte proliferation testing.
Harber P; Su J; Alongi G
J Occup Environ Med; 2014 Aug; 56(8):857-60. PubMed ID: 25099413
[TBL] [Abstract][Full Text] [Related]
29. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
[TBL] [Abstract][Full Text] [Related]
30. Long-term efficacy of a program to prevent beryllium disease.
Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
[TBL] [Abstract][Full Text] [Related]
31. Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.
Markham TN
Int Arch Occup Environ Health; 1996; 68(6):405-7. PubMed ID: 8891776
[No Abstract] [Full Text] [Related]
32. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease.
Hines SE; Pacheco K; Maier LA
Curr Opin Allergy Clin Immunol; 2012 Apr; 12(2):102-10. PubMed ID: 22306552
[TBL] [Abstract][Full Text] [Related]
33. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
[TBL] [Abstract][Full Text] [Related]
34. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
[TBL] [Abstract][Full Text] [Related]
35. Beryllium hypersensitivity and chronic beryllium lung disease.
Santo Tomas LH
Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
[TBL] [Abstract][Full Text] [Related]
36. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
Kreiss K; Wasserman S; Mroz MM; Newman LS
J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
[TBL] [Abstract][Full Text] [Related]
37. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey.
Deubner DC; Goodman M; Iannuzzi J
Appl Occup Environ Hyg; 2001 May; 16(5):521-6. PubMed ID: 11370932
[TBL] [Abstract][Full Text] [Related]
38. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
Newman LS; Kreiss K
Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
[TBL] [Abstract][Full Text] [Related]
39. Beryllium.
Deubner DC
J Occup Environ Hyg; 2005 Oct; 2(10):D74-6; author reply D76-8. PubMed ID: 16174633
[No Abstract] [Full Text] [Related]
40. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
